Observational studyCardiovascular intervention and therapeutics2026
Intravascular ultrasound evaluation of novel non-compliant versus conventional semi-compliant cutting balloon for calcified coronary lesions.
Observational study in Cardiovascular intervention and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutting balloons (CBs) are valuable tools for modifying calcified coronary lesions. However, few comparative studies have assessed the efficacy of different CBs in real-world practice. Therefore, we evaluated the dilatation efficacy and safety of a novel non-compliant CB (NCB) in a head-to-head comparison with a conventional semi-compliant CB (CCB). This single-center, prospective observational study included 50 consecutive calcified lesions treated with the NCB as the initial interventional device. Another 50 consecutive lesions treated with the CCB were retrospectively analyzed as a historical control. All lesions underwent intravascular ultrasound (IVUS) evaluation before and after dilatation with CB. The primary endpoints were post-modification minimum lumen area (post-CB MLA), change in MLA (ΔMLA), and crack formation at the MLA site. Secondary endpoints included the incidence of coronary dissection, perforation, and slow/no-reflow. Baseline patient and lesion characteristics were generally comparable between groups. Post-CB MLA was significantly larger in the NCB group than in the CCB group (4.26 ± 1.62 mm² vs. 3.45 ± 1.26 mm²; p = 0.007). ΔMLA was also greater in the NCB group (1.49 ± 0.97 mm² vs. 0.94 ± 0.65 mm²; p = 0.001). The NCB achieved more cracks per MLA cross-Sect. (2 [IQR 1-2] vs. 1 [IQR 1-1]; p = 0.014) and a lower incidence of malignant dissection (12% vs. 30%; p = 0.048). No coronary perforations or slow/no-reflow events occurred in either group. The NCB demonstrated superior lesion preparation performance, while maintaining a comparable safety profile, compared with the CCB in de-novo calcified lesions.
Indexed as
Identifiers
42192087What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.